NRAS and neoplasm: This initiative has led to the discovery of some key molecules and pathways including the vascular endothelial growth factor (VEGF) in tumor angiogenesis and the epidermal growth factor receptor (EGFR) with the therapy guiding KRAS/NRAS mutations.